Gestational diabetes mellitus (GDM) is a common pregnancy condition. In this study, the risk of having a history of previous GDM (pGDM) on serum homocysteine level was assessed
Biomedical parameters, serum homocysteine, Insulin, homeostatic model assessment (HOMA) in women with (n = 52) and without pGDM (n = 51) were assessed. According to their current status of Oral Glucose Tolerance Test (GTT), the participants in each group were divided into two subgroups of normal or impaired GTT.
Mean serum homocysteine in normal women was 8.56 ± 3.19 vs 11.44 ± 7.34 μmol/L (p < 0.01) in women with pGDM. Two groups had significant differences in respect to serum insulin levels (8.35 ± 5.12 vs 12.48 ± 5.44, p < 0.002), and HOMA-IR (1.90 ± 1.30 vs 2.91 ± 1.30, p < 0.002). In women without pGDM, serum homocysteine in normal and impaired GTT were 7.60 ± 1.69 and 10.52 ± 3.65 μmol/L (p = 0.03), respectively, while in women with pGDM, the figures were 8.38 ± 2.52 and 14.00 ± 10.17 (p < 0.01), respectively. In multi regression analysis an association between history of GDM and homocysteine levels was presented (OR: 7.71, 95% CI: 1.67-35.42, p < 0.001).
A trend of elevation of homocysteine is presented in women with pGDM, that is more prominent in women with impaired GTT, and shows a significant correlation with history of GDM. Further studies with larger sample size are suggested.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Gestational diabetes mellitus
Fasting blood sugar
Glucose tolerance test
Normal glucose tolerance test
Impaired glucose tolerance test
High density lipoprotein
Low density lipoprotein
Homoeostasis model assessment.
Ural SH, Repke JT: Gestational diabetes mellitus. Gilmartin AB. Rev Obstet Gynecol 2008,1(3):129–134. Summer
Hossein-Nezhad A, Maghbooli Z, Vassigh AR, et al.: Prevalence of gestational diabetes mellitus and pregnancy outcomes in Iranian women. Taiwan J Obstet Gynecol 2007,46(3):236–241. 10.1016/S1028-4559(08)60026-1
Stuebe AM, Mantzoros C, Kleinman K, et al.: Gestational glucose tolerance and maternal metabolic profile at 3 years postpartum. Obstet Gynecol 2011,118(5):1065–1073. 10.1097/AOG.0b013e3182325f5a
Vrachnis N, Augoulea A, Iliodromiti Z, Lambrinoudaki I, Sifakis S, Creatsas G: Previous gestational diabetes mellitus and markers of cardiovascular risk. Int J Endocrinol. 2012, 2012: 458610.
Kelly PJ, Rosand J, Plomaritoglou A, Chang Y, Kistler JP, Furie K: Mild-moderate hyperhomocysteinaemia and risk of stroke, result of a metaanalysis. Stroke 2000, 32: 366.
Sheu WH, Lee WK, Chen YT: Plasma homocysteine concentrations and insulin sensitivity in hypertensive subjects. Am J Hypertens 2000, 13: 14–20. 10.1016/S0895-7061(99)00138-7
Meigs JB, Jacques PF, Selhub J, et al.: Fasting plasma homocysteine levels in the insulin resistance syndrome: Framingham Offspring Study. Diab Care 2001, 24: 1403–1410. 10.2337/diacare.24.8.1403
Bar-On H, Kidron M, Friedlander Y, et al.: Plasma total homocysteine levels in subjects with hyperinsulinemia. J Intern Med 2000, 247: 287–297. 10.1046/j.1365-2796.2000.00592.x
Rosolová H, Simon J, Mayer O Jr, Racek J, Dierzé T, Jacobsen DW: Unexpected inverse relationship between insulin resistance and serum homocysteine in healthy subjects. Physiol Res 2002,51(1):93–98.
American Diabetes Association: Gestational Diabetes Mellitus. Diab Care 2004, 27: S88-S90.
Alfthan G, Laurinen MS, Valsta LM, Pastinen T, Aro A: Folate intake, plasma folate and homocysteine status in a random Finnish population. Eur J Clin Nutr 2003, 57: 81–88. 10.1038/sj.ejcn.1601507
DeFronzo RA, Abdul-Ghani MAJ: Preservation of β-cell function: the key to diabetes prevention. Clin Endocrinol Metab 2011,96(8):2354–2366. 10.1210/jc.2011-0246
Wajchenberg BL: beta-cell failure in diabetes and preservation by clinical treatment. Endocr Rev 2007,28(2):187–218.
Bonora E, Saggiani F, Targher G, et al.: Homeostasis Model Assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Diab Care 2000, 23: 23–25. 10.2337/diacare.23.1.23
Molęda P, Homa K, Safranow K, Celewicz Z, Fronczyk A, Majkowska L: Women with normal glucose tolerance and a history of gestational diabetes show significant impairment of β-cell function at normal insulin sensitivity. Diabetes Metab 2013,39(2):155–162. 10.1016/j.diabet.2012.11.003
Guven MA, Kilinc M, Batukan C, Ekerbicer HC, Aksu T: Elevated second trimester serum homocysteine levels in women with gestational diabetes mellitus. Arch Gynecol Obstet 2006, 274: 333–337. 10.1007/s00404-006-0191-6
Tarim E, Yigit F, Kilicdag E, et al.: Early onset of subclinical atherosclerosis in women with gestational diabetes mellitus. Ultrasound Obstet Gynecol 2006,27(2):177–182. 10.1002/uog.2687
Guldener CV: Why is homocysteine elevated in renal failure and what can be expected from homocysteine-lowering? Nephrol Dial Transplant 2006, 21: 1161–1166. 10.1093/ndt/gfl044
Wierzbicki AS: Homocysteine and cardiovascular disease: a review of the evidence. Diab Vasc Dis Res 2007, 4: 143.
Moat SJ, McDowell IF: Homocysteine and endothelial function in human studies. Semin Vasc Med 2005,5(2):172–182. 10.1055/s-2005-872402
The authors report no conflict of interest.
SA: Drafted the manuscript. HF: designed the study, intellectually revised the manuscript. FSh: designed the study, performed the analysis. MM: participated in study design. ZB: collected the data. MGH: participated in study design. AH: participated in study design. BL: approved the final version. All authors read and approved the final manuscript.
About this article
Cite this article
Alatab, S., Fakhrzadeh, H., Sharifi, F. et al. Correlation of serum homocysteine and previous history of gestational diabetes mellitus. J Diabetes Metab Disord 12, 34 (2013). https://doi.org/10.1186/2251-6581-12-34
- Gestational diabetes mellitus
- Diabetes mellitus